Oncology | Market Exclusive

Home Tags Oncology

Seattle Genetics, Inc. (NASDAQ:SGEN) Data Mixed, But That’s Only Half The...

- December 13, 2016 0

Here’s What To Look For When The Real GTx, Inc. (NASDAQ:GTXI)...

- November 17, 2016 0

Here’s Another Discount Entry Opportunity: TESARO Inc (NASDAQ:TSRO)

- November 16, 2016 0

Here’s Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A...

- November 15, 2016 0

Inovio Pharmaceuticals Inc (NASDAQ:INO) Looks Like A Nice Discount On The...

- October 25, 2016 0

Looking Ahead To The Potentially Game Changing TESARO Inc (NASDAQ:TSRO) Data

- September 13, 2016 0

Clovis Oncology Inc (NASDAQ:CLVS): Worth A Billion Dollars?

- September 9, 2016 0

Our Take On Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)’s Near Term Panel Review

- August 23, 2016 0

A Guess At What’s Behind The Adaptimmune Therapeutics PLC – ADR...

- August 4, 2016 0

What’s Next For CytRx Corporation (NASDAQ:CYTR) Holders?

- July 13, 2016 0

123...7 Page 2 of 7

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Oncology